The role of pars plana vitrectomy in the management of fungal endogenous endophthalmitis

Abstract

Purpose:

To identify the causative microorganism of fungal endogenous endophthalmitis in our tertiary referral uveitis center and review the therapeutic role of pars plana vitrectomy in patients with fungal endogenous endophthalmitis.

Methods:

Seven eyes of six cases were identified as fungal endogenous endophthalmitis through positive cultures of ocular fluids and clinical presentations. The final anatomical and functional results were evaluated.

Results:

Four women (66.7%) and two men (33.3%) underwent vitrectomy. Control of infection was achieved early on in all cases. Candida (71.4%) and Aspergillus (28.6%) species were identified as causative fungi in patients with fungal endogenous endophthalmitis. Two patients were reoperated due to reinfection and retinal detachment, respectively. Visual acuity improved in six eyes (85.7%) and worsened in one eye (14.3%). At the final examination, the retina was flat in all cases. No eye developed phthisis bulbi.

Conclusion:

Candida species are the most common causative organisms of fungal endogenous endophthalmitis in this study. Pars plana vitrectomy in fungal endogenous endophthalmitis may enhance the treatment of infection by removing fungal elements in the vitreous and aid in diagnosis. Vitrectomy may also be an important tool in the management of vision-threatening post-infectious sequelae such as retinal detachment and reinfections.

Keywords

Endogenous endophthalmitis fungal endophthalmitis infectious surgery vitrectomy

Get full access to this article

View all access options for this article.

References

Keynan

Finkelman

Lagace-Wiens

The microbiology of endophthalmitis: global trends and a local perspective. Eur J Clin Microbiol Infect Dis 2012; 31(11): 2879–2886.

Okada

Johnson

Liles

, et al. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 1994; 101(5): 832–838.

Paulus

Cheng

Karth

, et al. Prospective trial of endogenous fungal endophthalmitis and chorioretinitis rates, clinical course, and outcomes in patients with fungemia. Retina 2016; 36(7): 1357–1363.

Kresloff

Castellarin

Zarbin

MA.

Endophthalmitis. Surv Ophthalmol 1998; 43(3): 193–224.

Essman

Flynn

Jr Smiddy

, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1997; 28(3): 185–194.

Schiedler

Scott

Flynn

Jr , et al. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 2004; 137(4): 725–731.

Binder

Chua

Kaiser

, et al. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine 2003; 82(2): 97–105.

Chen

Sun

, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 2012; 154(1): 213–214.

Shrader

Band

Lauter

, et al. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990; 162(1): 115.

10.

Sridhar

Flynn

Jr Kuriyan

, et al. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect 2013; 3(1): 60.

11.

Lee

Joe

, et al. Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea. Retina 2012; 32(5): 977–984.

12.

Lou

, et al. A one-year follow-up study on the incidence and risk of endophthalmitis after pyogenic liver abscess. Ophthalmology 2012; 119(11): 2358–2363.

13.

Chavan

Mustafa

Narendran

, et al. A case of Candida albicans endophthalmitis with no predisposing risk factors and a distant source of infection. Case Rep Ophthalmol 2012; 3(3): 277–282.

14.

Birnbaum

Gupta

The role of early vitrectomy in the treatment of fungal endogenous endophthalmitis. Retin Cases Brief Rep 2016; 10(3): 232–235.

15.

Relhan

Albini

Flynn

, et al. Treating endogenous endophthalmitis. Rev Ophthalmol 2014, http://www.reviewofophthalmology.com/content/d/retinal_insider/c50867/ (accessed 4 June 2015).

16.

Shen

Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm 2009; 17(3): 148–152.

17.

Takebayashi

Mizota

Tanaka

Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefes Arch Clin Exp Ophthalmol 2006; 244(7): 816–820.

18.

Breit

Hariprasad

Mieler

, et al. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 2005; 139(1): 135–140.

19.

Chakrabarti

Shivaprakash

Singh

, et al. Fungal endophthalmitis: fourteen years’ experience from a centre in India. Retina 2008; 28(10): 1400–1407.

20.

Zhang

Wang

WJ.

Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina 2005; 25(6): 746–750.

21.

Martinez-Vazquez

Fernandez-Ulloa

Bordon

, et al. Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis 1998; 27(5): 1130–1133.

22.

Sallam

Taylor

Khan

, et al. Factors determining visual outcome in endogenous candida endophthalmitis. Retina 2012; 32(6): 1129–1134.

23.

Cho

Shin

Siegel

, et al. Endogenous endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm 2016; 26: 496–503.

24.

Christmas

Smiddy

WE.

Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1996; 27(12): 1012–1018.

25.

Anaissie

McGinnis

Pfaller

MA.

Clinical mycology. London, UK: Elsevier, 2009, p. 688.

26.

Souri

Green

WR.

Intravitreal amphotericin B toxicity. Am J Ophthalmol 1974; 78(5): 875–876.

27.

Baldinger

Doft

Burns

, et al. Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes. Br J Ophthalmol 1986; 70(9): 657–661.

28.

Jackson

Eykyn

Graham

, et al. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003; 48(4): 403–423.

29.

Leibovitch

Lai

Raymond

, et al. Endogenous endophthalmitis: a 13-year review at a tertiary hospital in South Australia. Scand J Infect Dis 2005; 37(3): 184–189.

30.

Wong

Chan

Lee

, et al. Endogenous bacterial endophthalmitis: an East Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology 2000; 107(8): 1483–1491.

31.

Chee

Eliott

The role of vitrectomy in the management of fungal endophthalmitis. Semin Ophthalmol 2017; 32(1): 29–35.